Table 1 Details of eight 89Zr-immunoPET patients
Scan # | Tracer | Sex | Weight in kg | Administered activity in MBq | Malignancy | Analyzed tracer avid lesions |
|---|---|---|---|---|---|---|
1 | 89ZR-Daratumumab | M | 87.5 | 66.2 | Multiple Myeloma | 2nd Rib right, Os ileum right, Vertebrae L3 |
2 | 89ZR-Daratumumab | F | 85.3 | 68.0 | Multiple Myeloma | Mandibula right, Clavicle right, Os ilium right |
3 | 89ZR-Daratumumab | M | 90.2 | 65.0 | Multiple Myeloma | Femora left, Scapula left, 7th Rib left, Femora left |
4 | 89ZR-Daratumumab | M | 110.7 | 68.3 | Multiple Myeloma | Os ileum right, Os sacrum, Soft tissue left shoulder |
5 | 89ZR-Pertuzumab | F | 66.0 | 70.7 | Breast Cancer | Vertebrae Th12, Femora left, Soft tissue retroperitoneal |
6 | 89ZR-Pertuzumab | F | 66.0 | 71.4 | Breast Cancer | Os ileum right, Os ischii right |
7 | 89ZR-Trastuzumab | F | 52.0 | 67.0 | Lung Cancer | Os ilium left, Spleen |
8 | 89ZR-Trastuzumab | M | 75.0 | 75.9 | Lung Cancer | Vertebrae T11, Node portocaval, Vertebrae T11, Scapula right |